Atossa Genetics Secures $6,600,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a46139e-6737-4dbc-afe6-54a06598961e&Preview=1 - Date
6/27/2011 - Company Name
Atossa Genetics - Mailing Address
4105 E Madison St Seattle, WA 98112 - Company Description
We are a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer. - Website
http://www.atossagenetics.com - Transaction Type
Venture Equity - Transaction Amount
$6,600,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds from the offering will be used to produce the MACST System in commercial quantities; establish a cytology and molecular diagnostics laboratory focused on breast health; launch the Mammary Aspirate Specimen Cytology Test System (MASCT System) in the Northwestern United States, including hiring and training sales personnel; continue development of the second generation MASCT System; and develop additional products and services. - M&A Terms
- Venture Investor
Undisclosed
